---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-050367"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2022-04-26T23:59:59+00:00"
generated_at: "2026-06-26T04:44:40.693852+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Petros Pharmaceuticals enters research agreement with Mass General for oxygenation sensor in erectile therapy

## Summary
- Signed Sponsored Research Agreement and Option Agreement with Wellman Center of Massachusetts General Hospital.
- Goal is to evaluate tissue-specific oxygenation sensor to monitor success of Erectile Device Therapy.
- Option agreement allows Petros to negotiate an exclusive license of the sensor technology for specific human tissues.
- Sensor intended to provide bio-sensor feedback for at-home penile therapy, enhancing existing erectile device therapy.

## SEC filing metadata
- accession: 0001104659-22-050367
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2022-04-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465922050367/0001104659-22-050367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465922050367/tm2213617d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-050367
- JSON: https://secwatch.observer/filing/0001104659-22-050367.json
- Plain text: https://secwatch.observer/filing/0001104659-22-050367.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.